Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Mesoblast Limited ( (AU:MSB) ) is now available.
Mesoblast Limited has announced the cessation of 3,000,000 MSBAB warrants after the conditional rights attached to these securities lapsed because their conditions were not, or could no longer be, satisfied. The lapse reduces the company’s pool of potential equity-linked instruments but does not involve an immediate capital raising or cash transaction, representing an adjustment to its capital structure rather than an operational change.
The most recent analyst rating on (AU:MSB) stock is a Buy with a A$4.00 price target. To see the full list of analyst forecasts on Mesoblast Limited stock, see the AU:MSB Stock Forecast page.
More about Mesoblast Limited
Average Trading Volume: 4,447,733
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$3.55B
See more insights into MSB stock on TipRanks’ Stock Analysis page.